Arjaans Sanne, Zwart Elvira A H, Ploegstra Mark-Jan, Bos Arend F, Kooi Elisabeth M W, Hillege Hans L, Berger Rolf M F
Department of Pediatric Cardiology, Center for Congenital Heart Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Department of Neonatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Paediatr Perinat Epidemiol. 2018 May;32(3):258-267. doi: 10.1111/ppe.12444. Epub 2018 Jan 17.
Pulmonary hypertension complicates the clinical course of extremely preterm infants and is associated with bronchopulmonary dysplasia (BPD). However, prevalence, risk factors, and outcome of pulmonary hypertension in these infants are insufficiently known. This systematic review and meta-analysis aims to provide an up-to-date overview of available data on prevalence, risk factors, and outcome of pulmonary hypertension and to identify current knowledge gaps.
Medline, EMBASE, and the Cochrane Library databases were searched in July 2017. Two authors reviewed titles/abstracts and full-texts. Eligible studies reported prevalence, patient characteristics or mortality of infants with/without pulmonary hypertension. Studies were excluded if they did not include extremely preterm infants. Only similar study samples (selected infants with BPD or infants both with/without BPD) were compared in the meta-analyses.
Of 1829 unique articles identified, 25 were eligible for inclusion. Pulmonary hypertension was observed in infants with BPD (20%, 95% confidence interval [CI] 14, 25), but also in those without BPD (2%, 95% CI 0, 8). Infants with severe BPD were most at risk of pulmonary hypertension (risk ratio [RR] 2.7, 95% CI 1.7, 4.2). Infants with pulmonary hypertension were more at risk of mortality (RR 4.7, 95% CI 2.7, 8.3).
Pulmonary hypertension occurs in particularly in infants with severe BPD, and increases risk of mortality. Due to selected study populations, heterogeneous pulmonary hypertension-definitions and poorly reported timing of pulmonary hypertension assessments, however, data available in current reports are insufficient to allow accurate assessment of true prevalence, risk factors, and time-related outcome. Prospective studies, with standardised methodology and follow-up are needed to determine these factors.
肺动脉高压使极早产儿的临床病程复杂化,并与支气管肺发育不良(BPD)相关。然而,这些婴儿中肺动脉高压的患病率、危险因素和结局尚不清楚。本系统评价和荟萃分析旨在提供有关肺动脉高压患病率、危险因素和结局的现有数据的最新概述,并确定当前的知识空白。
2017年7月检索了Medline、EMBASE和Cochrane图书馆数据库。两位作者审阅了标题/摘要和全文。符合条件的研究报告了有/无肺动脉高压婴儿的患病率、患者特征或死亡率。如果研究未纳入极早产儿,则将其排除。在荟萃分析中仅比较了相似的研究样本(选择的患有BPD的婴儿或有/无BPD的婴儿)。
在1829篇独特文章中,25篇符合纳入标准。BPD婴儿中观察到肺动脉高压(20%,95%置信区间[CI]14,25),但无BPD的婴儿中也有肺动脉高压(2%,95%CI0,8)。重度BPD婴儿患肺动脉高压的风险最高(风险比[RR]2.7,95%CI1.7,4.2)。患有肺动脉高压的婴儿死亡风险更高(RR4.7,95%CI2.7,8.3)。
肺动脉高压尤其发生在重度BPD婴儿中,并增加死亡风险。然而,由于研究人群的选择、肺动脉高压定义的异质性以及肺动脉高压评估时间报告不佳,当前报告中的数据不足以准确评估真实患病率、危险因素和与时间相关的结局。需要采用标准化方法和随访的前瞻性研究来确定这些因素。